Wednesday, May 13, 2020 11:00:26 AM
Apologies - Been drinking from the firehose with work these days and have not been able to comment.
To close the loop on a few things; I did dial-in to the Conf Call - overall great Q1 with persistent growth and the scaling has been highly accretive to the bottom line.
Some highlights I took down:
- Pharma growth persists despite the pandemic (2 new programs with one officially launched and one expected to commence shortly)
- As of April Plasma volumes are down 15%; note Q2 is seasonally weaker in terms of volumes and this is slightly more than usual due to Covid-19 (While this is hindered by the recent government checks that went out and the "stay at home" policies" we must also note they added many centers compare to last year so that will help ease the blow. In addition for those who have not seen it significant donation premiums are being given to people who are found to have Covid-19 antibodies). While this is the short term effect given Covid-19, typically recessions lead to MORE donations as more people try to find ways to come up with cash. When things open up this is likely to provide a strong tailwind to Plasma.
- Premier Card has been launched in addition to exploring other programs outside of Pharma and plasma to further diversify the business.
Current stock performance appears to be a little overdone and in my opinion likely due to some small weakness expected in Q2 - could be a great opportunity to pick it up at a discount for a longer-term growth play.
Overall the analyst community was Neutral to slightly positive on the company's outlook and Q1 results - mainly slight upgrades (1 decrease in PT):
Average Price Target is 11.50$
Ladenburg Thalmann: Q1 Points to Continued Impressive Growth Through 2021; Raising PT to 12$
Canaccord: Solid Start to the year; pharma stability to offset temporary plasma softness next quarter PT 11$
DA Davidson: Great Start to Year; Trimming Forecasts on Lower Visibility (PT: 11$ from 12$)
BTIG: PAYS Delivers Modestly Positive and Largely Uneventful 1Q20 Report, Refrains from Providing 2020 Guidance driven by Pandemic Uncertainty - Neutral No Target
Maxim Group: Revenue Beats Guidance; Solid Outlook; Maintain 2021 Revenue Estimate; Potential Covid Play - Raise PT to 12$ on valuation.
Recent PAYS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 12:47:12 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 08/08/2024 08:46:17 PM
- Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference • Business Wire • 08/08/2024 08:15:00 PM
- Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference • Business Wire • 08/07/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 01:16:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 01:16:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 01:16:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 01:15:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 01:15:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2024 01:16:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2024 01:16:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2024 01:15:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2024 01:15:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2024 01:15:16 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:47:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:02:32 PM
- Paysign, Inc. Reports Second Quarter 2024 Financial Results • Business Wire • 07/31/2024 08:02:00 PM
- Paysign to Host Second Quarter 2024 Earnings Call • Business Wire • 07/09/2024 08:30:00 PM
- Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25 • Business Wire • 06/20/2024 08:30:00 PM
- Paysign, Inc. to Participate in the 2024 iAccess Alpha Buyside Best Ideas Summer Conference • Business Wire • 06/18/2024 08:30:00 PM
- Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference • Business Wire • 06/06/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:49:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:47:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 10:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:57:15 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM